tiprankstipranks
Medipal Holdings Corporation (JP:7459)
:7459
Holding JP:7459?
Track your performance easily

Medipal Holdings (7459) Stock Price & Analysis

1 Followers

7459 Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

5.26%89.24%
Insiders
― Other Institutional Investors
89.24% Public Companies and
Individual Investors

7459 FAQ

What was Medipal Holdings Corporation’s price range in the past 12 months?
Medipal Holdings Corporation lowest stock price was ¥2170.50 and its highest was ¥2770.00 in the past 12 months.
    What is Medipal Holdings Corporation’s market cap?
    Medipal Holdings Corporation’s market cap is $428.05B.
      When is Medipal Holdings Corporation’s upcoming earnings report date?
      Medipal Holdings Corporation’s upcoming earnings report date is Feb 10, 2025 which is in 22 days.
        How were Medipal Holdings Corporation’s earnings last quarter?
        Medipal Holdings Corporation released its earnings results on Nov 01, 2024. The company reported ¥60.98 earnings per share for the quarter, beating the consensus estimate of ¥53.521 by ¥7.459.
          Is Medipal Holdings Corporation overvalued?
          According to Wall Street analysts Medipal Holdings Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Medipal Holdings Corporation pay dividends?
            Medipal Holdings Corporation pays a Annually dividend of ¥30 which represents an annual dividend yield of 2.64%. See more information on Medipal Holdings Corporation dividends here
              What is Medipal Holdings Corporation’s EPS estimate?
              Medipal Holdings Corporation’s EPS estimate is 37.65.
                How many shares outstanding does Medipal Holdings Corporation have?
                Medipal Holdings Corporation has 219,226,040 shares outstanding.
                  What happened to Medipal Holdings Corporation’s price movement after its last earnings report?
                  Medipal Holdings Corporation reported an EPS of ¥60.98 in its last earnings report, beating expectations of ¥53.521. Following the earnings report the stock price went down -2.123%.
                    Which hedge fund is a major shareholder of Medipal Holdings Corporation?
                    Currently, no hedge funds are holding shares in JP:7459
                    ---

                    Company Description

                    Medipal Holdings Corporation

                    Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. Its operations are carried out through the following segments: Prescription Pharmaceutical Wholesale Business; Cosmetics, Daily Necessities, and Over-The-Counter (OTC) Pharmaceutical Wholesale Business; and Animal Health Products Wholesale Business. The Prescription Pharmaceutical Wholesale Business segment conducts wholesale business for hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and OTC Pharmaceutical Wholesale Business segment deals with wholesale business for drugstores, home centers, convenience stores, and supermarkets. The Animal Health Products Wholesale Business segment handles wholesale business for animal hospitals, farms, agricultural cooperatives, and processed food manufacturers. The company was founded on October 8, 1898 and is headquartered in Tokyo, Japan.
                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Mitsubishi Shokuhin Co., Ltd.
                    Terumo
                    Sumitomo Dainippon Pharma Co
                    Shionogi & Co
                    Takeda Pharmaceutical Co
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis